Phase II GaRP-IBS Trial & Anti-Obesity Project Updates
Filed with ASX · · 4 pages · English
Anatara Lifesciences Ltd on 6ix
Earlier from Anatara Lifesciences
- Appendix 4D & Half Year Report 31 December 2024
- Australian Patent Granted for GaRP Product
- GaRP-IBS Clinical Trial Update
- Share Purchase Plan Offer Booklet
- Successful Placement of $660k and Share Purchase Plan
Later from Anatara Lifesciences
- Phase II GaRP-IBS Trial Headline Analysis of Results
- Funding Advance on R&D Refund
- Phase II GaRP-IBS Trial Internal Analyses of Data Subsets
- Hong Kong Patent Granted for GaRP
- Anatara receives $969,455 in R&D Tax Incentive for FY25
Follow Anatara Lifesciences into a list and get an email when it puts out news.
Follow Anatara Lifesciences